Blueprint Health Reflects, Rolls Out Latest Crew of Grads at Demo Day

providers into CredSimple’s engine, which verifies the qualifications of those practitioners with 214 different data sources. CredSimple then sends a report with its findings. “60 days of turnaround time we’re able to turn out in just four days, and in the process we’re cutting the cost of credentialing by half,” Simmons says.

Customers, such as insurance companies, pay a subscription fee based on the number of providers in their network or hospital.

SpotMe—A web-based platform that manages fitness benefits, such as gym memberships, for employers. An HR administrator signs on to its site, fills in the size of the benefit package, and how those benefits will be funded, and SpotMe handles the rest, according to CEO Jarrod Wolf. SpotMe charges customers between $99 and $499 per month, depending on the size of the company. It expects to have 500 customers by the middle of 2014, and 1,000 customers—and a $2 million annual run rate—by the end of that year, Wolf said.

BoardVitals—A test-preparation tool that is supposed to help physicians—specifically, those in specialty fields like pathology or psychiatry—pass their board exams. BoardVitals has an online bank of board exam questions with answer explanations, references and links to applicable sources, and statistical measures to track a student’s strengths and weakness, and how he/she is doing compared to other users. BoardVitals charges, on average, $99 per physician, per month—most use the service for 1.5 months. It currently has an annual run rate of about $350,000 per year, and is already profitable, says CEO Dan Lambert.

StaffInsight—A web-based analytical tool that tracks the productivity of workforces in hospitals and long-term care facilities. StaffInsight’s dashboards help healthcare facility managers identify which units are under- or overstaffed, establish benchmarks for improvement, model staffing to achieve those benchmarks, schedule hours, and track hours worked, according to CEO Cristopher Laibe. StaffInsight charges between $50,000 and $100,000 per year for its service, has partnerships with Cerner and Applied Management Systems, and is projecting $2 million in revenue in 2014, he says.

Healthify—Healthcare centers are financially incentivized to get certified as “Patient-Centered Medical Homes,” (PCMH) a model of care in which a team of providers coordinate all of a patient’s health needs. Unfortunately, according to Healthify CEO Manik Bhat, it’s tough to get. These centers have to meet a long list of qualifications—like conducting patient-by-patient screenings—and don’t have an efficient way to meet those benchmarks. Healthify has a screening tool that can conduct these screenings electronically, and give that information to a case manager, making it easier for these centers to qualify for PCMH status.

Genterpret—This startup helps pharmaceutical companies identify patients that will best respond to their experimental drugs. Genterpret uses targeted advertising to find people willing to share their genetic information, and after screening volunteers, gathers the data, combs through it for genetic variants linked to drug response, and sends a report to its pharmaceutical client, according to co-founder and Harvard University researcher Steve Hershman. Genterpet charges clients $1,000, per patient, for the data. Hershman says Genterpet is in talks with a “top five pharmaceutical company” to supply it with data for 2,000 patients with osteoporosis. Harvard genomics expert George Church is one of Genterpret’s advisors.

Artemis—Developer of a web-based platform that analyzes health claims data for self-insured employers. Artemis takes all third-party data—medical claims, pharmaceutical claims, health-risk assessments—pulls it together, analyzes it, finds where an employer can potentially save money, and makes suggestions based on what it finds. Clients pay an annual SaaS license fee of $50,000-$150,000 depending on the number of members they have, according to co-founder Grant Gordon.

Author: Ben Fidler

Ben is former Xconomy Deputy Editor, Biotechnology. He is a seasoned business journalist that comes to Xconomy after a nine-year stint at The Deal, where he covered corporate transactions in industries ranging from biotech to auto parts and gaming. Most recently, Ben was The Deal’s senior healthcare writer, focusing on acquisitions, venture financings, IPOs, partnerships and industry trends in the pharmaceutical, biotech, diagnostics and med tech spaces. Ben wrote features on creative biotech financing models, analyses of middle market and large cap buyouts, spin-offs and restructurings, and enterprise pieces on legal issues such as pay-for-delay agreements and the Affordable Care Act. Before switching to the healthcare beat, Ben was The Deal's senior bankruptcy reporter, covering the restructurings of the Texas Rangers, Phoenix Coyotes, GM, Delphi, Trump Entertainment Resorts and Blockbuster, among others. Ben has a bachelor’s degree in English from Binghamton University.